Clinical and pharmacological phase I evaluation of ExherinTM (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours (Q62944928)
Jump to navigation
Jump to search
scientific article published on 03 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical and pharmacological phase I evaluation of ExherinTM (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours |
scientific article published on 03 February 2009 |
Statements
Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours (English)
A Perotti
C Sessa
A Mancuso
C Noberasco
A Locatelli
M L Carcangiu
K Passera
A Braghetti
D Scaramuzza
F Zanaboni
A Fasolo
M Miani